MunaiMarkets Afinity Logo Transparent November 24 2024
Close

Analysis Of The 12 Largest Cannabis Companies Puts Green Thumb #1

Macro shot of flowering cannabis bud

Please Share This Article:

Facebook
Email
LinkedIn
X
Pinterest

Green Thumb Industries’ Q3 2024 financials clearly show that they are the top dog in the industry, planting seeds for long-term growth while keeping an eye on the bottom line.

Those familiar with my frequent articles on MunAiMarkets are aware that I post summaries of the quarterly financial reports of the 7 largest MSO and 5 largest LP cannabis stocks. These summaries are intended to provide insights into the progress of the financial health of those companies as a basis for making sound investment decisions. This article goes one giant step further and compares the major financial components of each company and ranks their overall financial health.

The financial metrics used in this analysis are a company’s Gross Profit margin; Selling General and Administration (SG&A) expenses; adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) and Net Profit or Loss Margin, each as a % of a company’s Net Revenue.  Source

Gross Profit Margins as a % of Net Revenue

Gross Profit Margin is the profit remaining after subtracting the cost of goods sold from revenue. A high gross profit margin indicates that a company is successfully producing profit over and above its costs.

Below are the gross profit margins as a % of net revenue of the 12 cannabis companies, ranked in descending order as per their most recent quarterly financial reports. Remember that a higher margin reflects better profitability and cost efficiency.

  • (1) Aurora Cannabis (ACB): 54.2%; (2) Ayr Wellness (AYRWF): 53.1%; (3) Green Thumb (GTBIF): 52.5%; (4) Verano (VRNOF): 51.0%; (5) Trulieve (TCNNF): 49.1%; (6) TerrAscend (TSNDF): 48.0%; (7) Cresco Labs (CRLBF): 47.1%; (8) Curaleaf (CURLF): 45.5%; (9) Tilray (TLRY): 26.2%; (10) Organigram (OGI): 25.5%; (11) Canopy Growth (CGC): 21.3%; (12) Cronos (CRON): (17.7)%

Selling, General, and Administrative (SG&A) Expenses as a % of Net Revenue

SG&A expenses are the costs a company incurs to run its business, which include salaries, marketing, rent, utilities, and office supplies and the SG&A margin is the percentage of revenue consumed by these expenses and shows how much revenue is being absorbed by overhead costs.

Below are the SG&A expenses as a % of net revenue of the 12 cannabis companies, ranked in descending order as per their most recent quarterly financial reports. In this instance a lower margin reflects how efficiently a company manages its operating expenses.

  • (1) Green Thumb (GTBIF): 25.0%; (2) Cresco Labs (CRLBF): 29.9%; (3) Curaleaf (CURLF): 32.1%; (4) Tilray (TLRY): 32.5%; (5) Trulieve (TCNNF): 34.0%; (6) TerrAscend (TSNDF): 34.7%; (7) Ayr Wellness (AYRWF): 35.6%; (8) Verano (VRNOF): 39.0%; (9) Canopy Growth (CGC): 52.3%; (10) Organigram (OGI): 53.6%; (11) Aurora Cannabis (ACB): 54.6%; (12) Cronos (CRON): (56.3)%

Adjusted EBITDA as a % of Net revenue

EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, represents the cash profit generated by the company’s operations. Adjusted EBITDA figures remove non-recurring, irregular, and one-time items such as Unrealized gains or losses; Non-cash expenses (depreciation, amortization); Litigation expenses; Gains or losses on foreign exchange; Goodwill impairments; Non-operating income; and Share-based compensation that may distort the EBITDA. The resultant adjusted EBITDA is more accurate when comparing it to the adjusted EBITDA of another companies in the industry.

Below are the Adj. EBITDA as a % of net revenue of the 12 cannabis companies, ranked in descending order as per their most recent quarterly financial reports. In this case, a higher margin reflects the cash profit generated by the company’s operations.

  • (1) Green Thumb (GTBIF): 35.7%; (2) Trulieve (TCNNF): 35.5%; (3) Verano (VRNOF): 30.3%; (4) Cresco Labs (CRLBF): 28.8%;  (5) Ayr Wellness (AYRWF): 24.7%; (6) Curaleaf (CURLF): 22.6%; (7) TerrAscend (TSNDF): 20.1%; (8) Tilray (TLRY): 3.4%; (9) Aurora Cannabis (ACB): 3.4%; (10) Organigram (OGI): (0.3)%; (11) Canopy Growth (CGC): (11.3); (12) Cronos (CRON): (42.2)%

Net Profit Margin or Loss as a % of Net Revenue

Net profit margin, or simply net margin, measures how much net income or profit a company generates as a percentage of its revenue. The net profit margin illustrates how much of each dollar in revenue collected by a company translates into profit.

Below are the net profit (loss) margins as a % of net revenue of the 12 cannabis companies, ranked in descending order as per their most recent quarterly financial reports. A higher margin reflects the cash profit generated by the company’s operations.

  • (1) Green Thumb (GTBIF): 11.3%; (2) Verano (VRNOF): (2.2)%; 3. Cresco Labs (CRLBF): (2.8)%; 4. Cronos (CRON): (8.9)%; (5) Trulieve (TCNNF): (10.7)%; (6) Curaleaf (CURLF): (14.3)%; (7) Ayr Wellness (AYRWF): (16.9)%; (8) TerrAscend (TSNDF): (18.4)%; (9) Aurora Cannabis (ACB): (29.2)%; (10) Tilray (TLRY): (49.2)%; (11) Organigram (OGI): (72.3)%; (12) Canopy Growth (CGC): (126.9)

In Summary

The sum rankings of the above analyses are listed below, in descending order, to provide an overall assessment of the financial strength of the 12 cannabis companies:

  • (1) Green Thumb (GBTIF); (2) Cresco Labs (CRLBF); (3) Trulieve (TCNNF): (4) Verano (VRNOF); (5) Ayr Wellness (AYRWF); (6) Curaleaf (CURLF); (7) TerrAscend (TSNDF); (8) Aurora Cannabis (ACB); (9) Tilray (TLRY); (10) Cronos (CRON); (11) Organigram (OGI); (12) Canopy Growth (CGC)

I am not aware of such a comprehensive comparative analysis of the cannabis industry being available elsewhere on the internet so I will keep this information updated on a quarterly basis.

A great way to substantiate that claim is to compare Green Thumb’s Adjusted EBITDA as a % of Revenue with its 6 largest competitors in the space as tracked in the MunAiMarkets American Cannabis MSO Stocks Index so, to that end, we list all 7 MSOs, in descending order of their latest performances in that regard below, as follows: 

  1. Trulieve Cannabis (TCNNF): Adj. EBTIDA as a % of Revenue: 37.8%
  2. Green Thumb Industries (GTGIF): 31.1%
  3. Verano Holdings (VRNOF): 29.8%
  4. Cresco Labs (CRLBF): 28.5%
  5. Curaleaf (CURLF): 22.8%
  6. TerrAscend (TSNDF): 18.5%
  7. Ayr Wellness (AYRWF): Not yet available

Like our new site? Here are 10 ways to get involved:

  1. Listen to the MunAiMarkets theme song and join the rich man’s world!
  2. Follow MunAiMarkets on Facebook and never miss an article.
  3. Share this article on LinkedIn, X and/or Pinterest.
  4. Watch our latest video posts on youtube.
  5. Comment on the articles and ask any questions you have.
  6. Submit an article for posting consideration.
  7. Become the site’s primary contributor and a full partner.
  8. Advertise on the MunAiMarkets banner for a token $10/mo. in 2025.
  9. Sponsor one of the site categories or an individual article for a modest fee.
  10. Support our efforts with a modest financial contribution.

Please Share This Article:

Facebook
Email
LinkedIn
X
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Unlock Your Potential with a Full Partnership Offer From Lorimer Wilson

MunAiMarkets is a new leading-edge financial site and we’re looking for an individual with the time and enthusiasm to contribute 7-10 articles per week leading to full partnership in 2025 when I retire.

Join us in a unique partnership where your contributions drive success. Experience unparalleled support as you engage with industry experts. Together, we’ll cultivate growth and innovation, ensuring a lasting impact for all stakeholders involved.

INTERESTED LETS TALK

Know Someone Who May Be Interested? Please Share

Facebook
X
LinkedIn
Email